Injectable GLP-1 Mechanism: Subcutaneous Injection: When you inject semaglutide or tirzepatide under the skin: Medication forms depot: Creates a small reservoir under the skin Slow absorption: Gradually releases into bloodstream over days Steady drug levels: Maintains consistent therapeutic concentration for one week Nearly complete bioavailability: Almost all medication reaches systemic circulation Predictable dosing: Precise amount of medication absorbed Why This Works So Well: Bypasses digestive system completely No breakdown by stomach acid or enzymes Consistent absorption across patients Once-weekly dosing maintains stable drug levels Can use relatively small doses for maximum effect Oral GLP-1 Mechanism (Rybelsus): Tablet Absorption Process: When you swallow Rybelsus: SNAC creates temporary window: Absorption enhancer raises stomach pH and increases permeability Limited absorption time: 30-minute window before medication moves to small intestine Most medication destroyed: Stomach acid and enzymes break down 99%+ of semaglutide Small amount reaches bloodstream: Less than 1% absorbed Rapid clearance: Daily dosing needed to maintain any therapeutic level Why This Is Challenging: Requires much higher doses (14 mg oral vs 2.4 mg injectable weekly) Strict timing requirements Variable absorption between patients Food, beverages, and other medications interfere with absorption Still less effective despite higher doses Pharmacokinetic Comparison: Absorption Challenges for Oral Peptides: Size Matters: GLP-1 medications are large molecules (peptides with 30-40 amino acids)

However, patients with known liver disease or elevated baseline liver enzymes may benefit from periodic monitoring based on individual clinical judgment
and overall apoB-containing lipoproteins ), We do NOT have sufficient evidence to assert that they: treat autoimmune diseases cure chronic pain syndromes treat fibromyalgia reverse structural joint damage reliably reduce atherosclerotic plaque inflammation on PET-MRI endpoints in general populations (current evidence is mixed/limited) Disclaimer: This article is for educational purposes only and is not a substitute for medical advice
The FDA-approved drug Zepbound, which Eli Lilly manufactures, may be covered under certain plans
Contact Columbine Aesthetics Botox and Medspa in Littleton, CO, today to schedule your personalized consultation and discover why clients trust us for expertise, artistry, and exceptional care.
5 mg/mL (low concentration) This concentration is ideal for patients in the early stages of their titration who need small, precise doses